External Review Board | Center for Biotechnology – Stony Brook University

Close

Donate

Whether your personal interests are in supporting innovation, bringing lifesaving biomedical products to patients, training the next generation of biomedical leaders or fueling our economy, the Center for Biotechnology provides a vehicle to accomplish great things. Things that matter. Things that change, and save, lives. Your involvement is an essential part of our future. Please consider a gift to the Center for Biotechnology which will help fuel innovation by ensuring that lifesaving technologies make it out of research labs and into the hands of patients. Give to the Center for Biotechnology online through the Stony Brook Foundation. Contributions can be made to our Fund for Excellence. More information about donating through the Stony Brook Foundation can be found here.

WHO WE ARE

Management Team & Advisory Board

External Review Board

Marc Appel, JD, MBA
Colleen Cuffaro, PhD

Principal, Canaan Partners
Daniel Forler, PhD

Senior Director, Early Licensing, Bayer U.S. Pharma (LEAPs program)
John D. Haley, PhD

Associate Professor, Pathology, Stony Brook University; Director, Developmental Therapeutics, Stony Brook Cancer Center; Director, Stony Brook University Proteomics Center
Kenton C. Hasson, PhD

Director of Strategic Partnerships, ANGLE plc
Brandy Houser, PhD

Site Head, New York, NY, Celdara Medical
Thomas D. Ippolito

Vice President, Clinical and Regulatory Affairs, Chembio Diagnostic Systems, Inc.
Sathapana (Sam) Kongsamut, PhD

President, Rudder Serendip LLC.
Jonathan Mandelbaum, PhD

Vice President, Private Equity, OrbiMed
Michael E. Marino, PhD

Manager, Drug Product Analytical Technologies, Regeneron Pharmaceuticals
Annie Mitsak, PhD

Partner, Cure Ventures
Stephanie C. Oestreich, PhD, MPA

Managing Director, Myeloma Investment Fund, MMRF
Christopher O’Donnell, PhD

Executive Director, External Science & Innovation and Principal, Pfizer Ventures.
Barbara Sawitsky

Director of Patents and Licensing, New York Blood Center
Tara Sharif, PhD

Managing Director WestPark Capital, Inc.
Stephanie Stehman, PhD

Sr. Director, Business Development, Spark Therapeutics, Inc.
James R. Tonra, PhD

President & CSO, Seed Therapeutics
Heather Walsh, PhD

Executive Director, Head of New Business Opportunities, Rx+ Business Accelerator, Astellas Pharma
Leigh Zawel, PhD

Executive-in-Residence, Atlas Venture; CSO, Pheon Therapeutics
Leah Lipsich, PhD

Executive Director, Program Direction, Immunology & Inflammation, Regeneron Pharmaceuticals, Inc.
Peter Young, MBA

Venture Partner
Pappas Capital